Get started
Author

Maria Laura Tanda

Observed names: L. Tanda, M L Tanda, M. L. Tanda, M. TANDA, M. Tanda, M.L. Tanda, MARIA LAURA TANDA, ML Tanda, Maria L Tanda, Maria L. TANDA, Maria L. Tanda, Maria Laura Piera Tanda, Maria Laura Tanda ve Eliana Piantanida, Maria Tanda, TANDA, MARIA LAURA PIERA, Tanda, Tanda M. L., Tanda, Maria Laura
Observed institutions: University of Pisa, University of Insubria, Ospedale di Circolo e Fondazione Macchi, Ospedale Cisanello, Azienda Ospedaliera Universitaria Pisana, Aziende Socio Sanitarie Territoriale dei Sette Laghi
ORCID: 0000-0001-7551-1751
Observed ORCID: 0000-0001-7551-1751
OpenAlex ID: A5065355995
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy
2021 · L Bartalena, G J Kahaly, et al. · European Journal of Endocrinology · 1,057
PDF
Relation between Therapy for Hyperthyroidism and the Course of Graves' Ophthalmopathy
1998 · Luigi Bartalena, Claudio Marcocci, et al. · New England Journal of Medicine · 717
PDF
Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy
2020 · Luigi Bartalena, Eliana Piantanida, et al. · Frontiers in Endocrinology · 370
PDF
Graves' Ophthalmopathy
2009 · Luigi Bartalena, Maria Laura Tanda · New England Journal of Medicine · 342
PDF
Prevalence and Natural History of Graves' Orbitopathy in a Large Series of Patients With Newly Diagnosed Graves' Hyperthyroidism Seen at a Single Center
2013 · M. L. Tanda, E. Piantanida, et al. · The Journal of Clinical Endocrinology & Metabolism · 327
PDF
Comparison of the Effectiveness and Tolerability of Intravenous or Oral Glucocorticoids Associated with Orbital Radiotherapy in the Management of Severe Graves' Ophthalmopathy: Results of a Prospective, Single-Blind, Randomized Study
2001 · Claudio Marcocci, Luigi Bartalena, et al. · The Journal of Clinical Endocrinology & Metabolism · 312
Cigarette Smoking and Treatment Outcomes in Graves Ophthalmopathy
1998 · Luigi Bartalena, Claudio Marcocci, et al. · Annals of Internal Medicine · 295
Current concepts regarding Graves’ orbitopathy
2022 · Luigi Bartalena, Maria Laura Tanda · Journal of Internal Medicine · 197
PDF
The interplay between thyroid and liver: implications for clinical practice
2020 · E. Piantanida, S. Ippolito, et al. · Journal of Endocrinological Investigation · 176
SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report
2020 · S. Ippolito, F. Dentali, et al. · Journal of Endocrinological Investigation · 152
PDF
Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography
1999 · F Bogazzi, L Bartalena, et al. · European Journal of Endocrinology · 134
Lower Dose Prednisone Prevents Radioiodine-Associated Exacerbation of Initially Mild or Absent Graves’ Orbitopathy: A Retrospective Cohort Study
2010 · Adriana Lai, Lorenza Sassi, et al. · The Journal of Clinical Endocrinology & Metabolism · 129
Prevalence and natural history of Graves' orbitopathy in the XXI century.
2013 · E Piantanida, M L Tanda, et al. · PubMed · 120
Orbital Radiotherapy for Graves' Ophthalmopathy
2002 · Luigi Bartalena, Claudio Marcocci, et al. · Thyroid · 116
Cigarette smoking and the thyroid
1995 · Luigi Bartalena, Fausto Bogazzi, et al. · European Journal of Endocrinology · 115
The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case‐control study
1999 · Marcocci, Marcocci, et al. · Clinical Endocrinology · 109
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH)
2017 · Marco Bonomi, Valeria Vezzoli, et al. · European Journal of Endocrinology · 103
PDF
Efficacy and Safety of Orbital Radiotherapy for Graves' Orbitopathy
2012 · Maria Laura Tanda, Luigi Bartalena · The Journal of Clinical Endocrinology & Metabolism · 100
Diagnosis and management of amiodarone‐induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association
2004 · Luigi Bartalena, Wilmar M. Wiersinga, et al. · Clinical Endocrinology · 89
Impact of Lithium on Efficacy of Radioactive Iodine Therapy for Graves’ Disease: A Cohort Study on Cure Rate, Time to Cure, and Frequency of Increased Serum Thyroxine After Antithyroid Drug Withdrawal
2009 · Fausto Bogazzi, Clara Giovannetti, et al. · The Journal of Clinical Endocrinology & Metabolism · 87
Antithyroid drug treatment for Graves’ disease: baseline predictive models of relapse after treatment for a patient-tailored management
2018 · E. Masiello, G. Veronesi, et al. · Journal of Endocrinological Investigation · 82
Diagnosis and management of amiodarone‐induced thyrotoxicosis: similarities and differences between North American and European thyroidologists*
2008 · Maria Laura Tanda, Eliana Piantanida, et al. · Clinical Endocrinology · 81
Oxidative stress and Graves' ophthalmopathy: In vitro studies and therapeutic implications
2003 · Luigi Bartalena, Maria Laura Tanda, et al. · BioFactors · 80
Glucocorticoid Response in Amiodarone-Induced Thyrotoxicosis Resulting from Destructive Thyroiditis Is Predicted by Thyroid Volume and Serum Free Thyroid Hormone Concentrations
2006 · Fausto Bogazzi, Luigi Bartalena, et al. · The Journal of Clinical Endocrinology & Metabolism · 79
PDF
Proportion of type 1 and type 2 amiodarone‐induced thyrotoxicosis has changed over a 27‐year period in Italy
2007 · Fausto Bogazzi, Luigi Bartalena, et al. · Clinical Endocrinology · 74
Works count: 271
Citation count: 8,053
H-index: 43
I10-index: 99
Year
Topic
Type